Your browser doesn't support javascript.
loading
Adjuvant Effects of Health Education of Chinese Medicine for Chronic Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Wang, An-Lu; Zhang, He; Zhang, Jie; Zhang, Yan; Cao, Hui-Juan; Liu, Jian-Ping; Xu, Hao; Chen, Ke-Ji.
Afiliação
  • Wang AL; Beijing University of Chinese Medicine, Beijing, China.
  • Zhang H; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Zhang J; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Zhang Y; Beijing University of Chinese Medicine, Beijing, China.
  • Cao HJ; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Liu JP; Beijing University of Chinese Medicine, Beijing, China.
  • Xu H; Beijing University of Chinese Medicine, Beijing, China.
  • Chen KJ; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Article em En | MEDLINE | ID: mdl-32328127
ABSTRACT

OBJECTIVE:

To evaluate the adjuvant effects of health education of Chinese medicine (HECM) for patients with three types of common noncommunicable diseases (NCD-hypertension, diabetes, and coronary heart disease (CHD)).

METHODS:

The protocol of this review was registered in the PROSPERO website (CRD42017058325). Six databases were searched till Sep. 30, 2019. Randomized controlled trials (RCTs) comparing HECM plus conventional therapy with conventional therapy were retrieved. Participants were diagnosed as one of the 3 above NCDs. HECM is regarded as lectures and classes about diet therapy, exercise therapy, emotion balance, and other knowledge according to Chinese medicine theory. The control rate of the disease was defined as a primary outcome in this review. Outcomes were synthesized using meta-analyses where reporting was sufficiently homogeneous or alternatively synthesized in a systematic review.

RESULTS:

In total, 12 trials with 1142 patients were included in this review. Since all the trials may have unclear or high risk of bias, only low quality evidence could be found for supporting the adjunctive effect of HECM in treating hypertension, diabetes, and CHD, to reduce the control rate (risk ratio -1.58), the blood pressure level (mean difference -9.38 mmHg), the fasting plasma glucose level (mean difference -1.26 mmol/L), and the symptoms of angina.

CONCLUSION:

The adjunctive effect of HECM on increasing the control rate of hypertension, improving the symptoms of diabetes and CHD, was only supported by low-quality evidence in this review. More rigorous trials with larger sample sizes and higher quality are warranted to provide a high quality of evidence.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Systematic_reviews Idioma: En Revista: Evid Based Complement Alternat Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Systematic_reviews Idioma: En Revista: Evid Based Complement Alternat Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China